Zhu, G., Cai, W., Wang, J., Chen, J., Qiu, F., Zhu, R., Sun, H., Wu, J., Yu, T., Si, X., Tian, S., Zhang, P., Wang, X., Wu, J. (2026). A retrospective study of donafenib with or without TACE as postoperative adjuvant therapy for hepatocellular carcinoma (HCC) patients at high risk of recurrence after radical resection.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16258